Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02185144 · ClinicalTrials.gov registry record · NA
PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT02185144: Completed NA study, sponsored by University of Pennsylvania.
NCT02185144 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 129 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02185144, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The PATH for Triples (PFT) Study is an effectiveness trial comparing a nurse health navigator (NHN) model for HIV+ persons with severe mental illness and substance abuse (i.e., triply diagnosed) with Treatment as Usual (TAU). The team completed a Phase II trial of the nurse health navigator model for HIV+ persons with severe mental illness that showed the intervention was effective. The investigators are now testing the intervention in a real world setting with patients recruited from psychiatric and substance abuse inpatient units in Philadelphia using a longitudinal design. The intervention is set up as a cascade where non-adherent patients receive additional visits from the study nurses. It is hypothesized that patients assigned to the NHN will have better medication compliance, reduced viral loads and improved CD4 counts compared to patients assigned to TAU. It is also hypothesized that the PFT intervention group will be more cost effective compared to TAU. This group of triply diagnosed patients are at very high risk of negative health outcomes and secondary transmission of HIV and, therefore, the study is of high public health significance.
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL PATH For Triples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2014-02 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02185144
The ClinicalTrials.gov registry entry for NCT02185144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT02185144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02185144 about?
NCT02185144 is a clinical study titled "PATH For Triples Study: Medication and Lifestyle Adherence for HIV+ Patients". The PATH for Triples (PFT) Study is an effectiveness trial comparing a nurse health navigator (NHN) model for HIV+ persons with severe mental illness and substance abuse (i.e., triply diagnosed) with Treatment as Usual (TAU). The team completed a Phase II trial of the nurse health navigator model fo...
What is the current status of trial NCT02185144?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2014-02. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02185144?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), PATH For Triples (BEHAVIORAL).
Who is sponsoring clinical trial NCT02185144?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.